NewSquare Capital’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-60	Closed	-$286	–	685
2023 Q2	$286	Hold	60	–	–	﹤0.01%	737
2023 Q1	$342	Hold	60	–	–	﹤0.01%	745
2022 Q4	$605	Buy	+60	New	+$605	﹤0.01%	634